- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06226311
Environmental Pollutants in Pregnancy - IoMumNEXT (IoMumNEXT)
Environmental Pollutants in Pregnancy - Exposure Assessment and Association With Early Childhood Development - IoMumNEXT
Study Overview
Status
Intervention / Treatment
Detailed Description
IoMumNEXT is a prospective observational study which will take advantage of our previous IoMum project - monitoring of iodine status in Portuguese pregnant women: impact of supplementation (Clinical Trials record: NCT04010708), a prospective observational study that has set up a cohort of 1155 pregnant women, living in the Porto and Lisbon Metropolitan Areas.
In a subsample of 199 pregnant women of this IoMum@Porto cohort it was already possible to conclude that:
- 19 and 32% of women had urinary levels (first trimester) of lead (208Pb) and arsenic (75As), respectively above the corresponding reference values (> 4 microg / L for Pb and> 35 microg / L for As).
- Maternal urinary Pb levels (first trimester) revealed a positive association with birth weight and length.
- Maternal urinary levels of As (first trimester) revealed a positive association with head circumference at birth.
- In a subsample of 69 pregnant women, 52% showed urinary 3-Phenoxybenzoic acid (3-PBA) levels above the detection level.
In addition to Pb, As and 3-PBA, the maternal urinary concentrations of other pollutants such as the elements lithium (7Li), cadmium (111Cd) and mercury (80Hg), and the pesticide metabolite trichloro-pyridinol (TCPY) will be analyzed. The continuity of this work will allow an important scientific advance, regarding the association between exposure to environmental pollutants and the physical and neurobehavioral development of children.
This proposal is in line with goal 3 (Health and well-being) of the United Nations Agenda 2030.
The study population will be composed of the pregnant women from the IoMum cohort as well as by their children born from this cohort. Maternal urine samples collected in the first trimester (T1) and third trimesters (T2) of pregnancy will be used, as well as urine samples from children collected between 3 and 6 years of age. Sociodemographic, lifestyle, anthropometric and health data will continue to be collected between 3 and 4 years of age (T3) and between 5 and 6 years of age (T4). Additionally, neurodevelopment will be assessed by Vineland adaptative behaviour scale at T3 and T4.
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Elisa Keating, PhD
- Phone Number: (+351) 225513624
- Email: keating@med.up.pt
Study Contact Backup
- Name: Janete Santos, PhD
- Phone Number: (+351) 225 513 600
- Email: investigaclinica@med.up.pt
Study Locations
-
-
-
Porto, Portugal, 4200-319
- Faculty of Medicine (FMUP)
-
Contact:
- Elisa Keating, PhD
- Phone Number: (+351) 225513624
- Email: keating@med.up.pt
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Have had single live birth
- Have provided contact and a urine sample T1
- Have provided consent to participate at T1
- Have provided consent to participate at T3
Exclusion Criteria:
Pregnancy complications
- Congenital malformations
- Gestational diabetes
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Children of IoMum pregnants cohort
IoMum participants without congenital malformations or gestational diabetes, with a singleton pregnancy with live birth, who provided contact and a T1 urine sample, will be invited to participate under signed informed consent.
|
Collection of sociodemographic, lifestyle and health data; Child anthropometry (weight, height and head circumference) at the ages of 3-4 and 5-6 years Child neurodevelopment scores at the ages of 3-4 and 5-6 years
Trichloro-pyridinol (TCPy) and 3-phenoxybenzoic acid (3-PBA) Environemental oligoelements including Lithium (7Li), Arsenic (75As), Cadmium (111Cd), Lead (208Pb) and Mercury (80Hg)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Anthropometric measurements of children - Weight
Time Frame: The information will be collected at baseline by telephone contact (3-4 years of age) with parents or legal representatives or by direct, in person, measurement (5-6 years of age)
|
Information n the weight (in kilograms) of children aged between 3-4 and 5-6 years will be recorded
|
The information will be collected at baseline by telephone contact (3-4 years of age) with parents or legal representatives or by direct, in person, measurement (5-6 years of age)
|
|
Anthropometric measurements of children - Height
Time Frame: The information will be at baseline collected by telephone contact (3-4 years of age) with parents or legal representatives or by direct, in person, measurement (5-6 years of age)
|
Information on the height (in centimeters) of children aged between 3-4 and 5-6 years will be recorded
|
The information will be at baseline collected by telephone contact (3-4 years of age) with parents or legal representatives or by direct, in person, measurement (5-6 years of age)
|
|
Neurodevelopment scores of children
Time Frame: At 3-4 and 5-6 years old of the children, parents will answer a questionnaire regarding daily living, social, communication and motor skills adjusetd to the specific age group, at baseline
|
Communication, daily life activities, socialization and motor skills will be assessed using the Vineland Adaptive Behavior Scale
|
At 3-4 and 5-6 years old of the children, parents will answer a questionnaire regarding daily living, social, communication and motor skills adjusetd to the specific age group, at baseline
|
|
1st trimester maternal urinary concentrations of environmental pollutants
Time Frame: Between gestational weeks 10 and 13 plus 6 days (Timepoint 1)
|
Median urinary concentations of 3-PBA, TCPY in micrograms per liter
|
Between gestational weeks 10 and 13 plus 6 days (Timepoint 1)
|
|
1st trimester maternal urinary concentrations of oligoelements
Time Frame: Between gestational weeks 10 and 13 plus 6 days (Timepoint 1)
|
Median urinary concentations of Pb, As, Cd, Li, Hg in micrograms per liter
|
Between gestational weeks 10 and 13 plus 6 days (Timepoint 1)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
1st trimester maternal urinary concentration of iodine
Time Frame: Between gestational weeks 10 and 13 plus 6 days (Timepoint 1)
|
Median urinary iodine concentrations at 1st trimester of gestation, in micrograms per liter
|
Between gestational weeks 10 and 13 plus 6 days (Timepoint 1)
|
|
3rd trimester maternal urinary concentration of environmental pollutants
Time Frame: Between gestational weeks 37 and 40 plus 6 days (Timepoint 2)
|
Median urinary concentations of 3-PBA, TCPY, in micrograms per liter
|
Between gestational weeks 37 and 40 plus 6 days (Timepoint 2)
|
|
3rd trimester maternal urinary concentration of oligoelements
Time Frame: Between gestational weeks 37 and 40 plus 6 days (Timepoint 2)
|
Median urinary concentations of oligoelements including Pb, As, Cd, Li, Hg, in micrograms per liter
|
Between gestational weeks 37 and 40 plus 6 days (Timepoint 2)
|
|
Anthropometric measures of the children at birth, 1, 2 and 4 years - Weight
Time Frame: Birth, 1, 2 and 4 years of age (retrospectively collected at the same moment, during the first phone call)
|
Weight information in grams or kilograms will be collected retrospectively from the clinical records or reported by the parents
|
Birth, 1, 2 and 4 years of age (retrospectively collected at the same moment, during the first phone call)
|
|
Anthropometric measures of the children at birth, 1, 2 and 4 years - Height
Time Frame: Birth, 1, 2 and 4 years of age (retrospectively collected at the same moment, during the first phone call)
|
Stature information in centimeters will be collected retrospectively from the clinical records or reported by the parents
|
Birth, 1, 2 and 4 years of age (retrospectively collected at the same moment, during the first phone call)
|
|
Anthropometric measures of the children at birth, 1 and 2 years - Head circumference
Time Frame: Birth, 1 and 2 years of age (retrospectively collected at the same moment, during the first phone call)
|
Head circumference in centimeters will be collected retrospectively from the clinical records or reported by the parents
|
Birth, 1 and 2 years of age (retrospectively collected at the same moment, during the first phone call)
|
|
Apgar index
Time Frame: Birth (retrospectively collected)
|
Apgar index at 1, 5 and 10 minutes
|
Birth (retrospectively collected)
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Elisa Keating, PhD, Faculty of Medicine (FMUP)
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- IoMumNEXT
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Early Childhood, Neurodevelopment
-
Yale UniversityMassachusetts Institute of Technology; Jameel (Abdul Latif) Poverty Action... and other collaboratorsCompleted
-
University of AlexandriaRecruitingEarly Childhood CariesEgypt
-
Cairo UniversityActive, not recruiting
-
Universiti Teknologi MaraCompletedEarly Childhood CariesMalaysia
-
Boston UniversityUnited States Agency for International Development (USAID); Swiss Tropical... and other collaboratorsCompletedEarly Childhood DevelopmentZambia
-
Stanford UniversityJohns Hopkins University; University of California, Berkeley; International Centre... and other collaboratorsCompletedEarly Childhood DevelopmentBangladesh
-
Duke UniversityCatholic Relief ServicesCompleted
-
Trakya UniversityCommission of Scientific Research Projects of Trakya University (TÜBAP)CompletedEarly Childhood CariesTurkey
-
Cairo UniversityUnknownEarly Childhood Caries
-
October University for Modern Sciences and ArtsCompleted
Clinical Trials on Data collection
-
Care Management PlusCompletedHealth Information Technology | Nurse Based Care ManagementUnited States
-
University Hospital, Basel, SwitzerlandRecruitingInfections With CPBSwitzerland
-
M.D. Anderson Cancer CenterUnknownPediatric CancerUnited States
-
GlaxoSmithKlineCompletedInfections, StreptococcalRomania, Slovenia, Poland, Lithuania, Estonia
-
GCS Ramsay Santé pour l'Enseignement et la RechercheCompleted
-
Assistance Publique - Hôpitaux de ParisURC-CIC Paris Descartes Necker CochinCompleted
-
Xuanwu Hospital, BeijingRecruitingMultiple Sclerosis | Myasthenia Gravis | Autoimmune Encephalitis | Acute Disseminated Encephalomyelitis | NMO Spectrum Disorder | Myelin Oligodendrocyte Glycoprotein Antibody-associated DiseaseChina
-
Centre Hospitalier Universitaire de Saint EtienneRecruitingCerebrospinal; DisorderFrance
-
Women and Infants Hospital of Rhode IslandTerminated
-
Centre Hospitalier Universitaire DijonCompletedCoronary Artery Bypass Graft | Anomalies in Glucose MetabolismFrance